Description
This product utilizes engineered Tregs that have been engineered with our proprietary GeneCircuit technology to specifically target FLT3 ( clone FLL82). We employs the Lentivirus (T7-mScarlet-IL-17-EcoRI) vector components and the SynExpress system of the exons Inversion/Delayed feedback for a robust and sustained response against cancers.
Host
humanized
Target
FLT3
Clone
FLL82
Species Reactivity
human
Cell Source
Engineered Tregs
Sensor Gene
mScarlet
Promoter
T7
Effector Gene
IL-17
Insertion Sites
EcoRI
Gene Modification
Inversion
Modification Domain
Exons
Carrier Type
Lentivirus
Transformation Accuracy
0.88
Cell Culture
Suspension Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.